The new weight loss jab trick the A-listers love... and it doesn't just keep the weight off, there's a raft of other health benefits and NO side effects
Share:
I was in the doldrums of perimenopause with high cholesterol (6.6mmol/L – below 5 is healthy) a prediabetic blood count and a stone and a half of excess weight giving me crippling lower back pain, when I began Ozempic in April 2023. Having heard all the side-effects horror stories (nausea, stomach cramps, constipation or at worst an increased risk of pancreatitis and thyroid cancer), it was not a decision taken lightly.
![[A friend told Olivia Falcon about the microdosing trick when taking Mounjaro to maintain weight loss]](https://i.dailymail.co.uk/1s/2025/01/05/15/93755229-14252019-A_friend_told_Olivia_Falcon_about_the_microdosing_trick_when_tak-m-36_1736090636328.jpg)
Under the care of Dr Wendy Denning, a private GP in London, I began on a 0.25mg weekly dose which I gradually increased over four months so my body adjusted slowly. Thanks to this, I dodged most side-effects – although I did suffer excessive hair loss for a while. Now, three months after I've stopped the semaglutide jabs. I've never felt better and my health is transformed.
![[Mounjaro is known as the King Kong of weight loss jabs because of its dual-action impact on the metabolism]](https://i.dailymail.co.uk/1s/2025/01/05/15/93755271-14252019-image-a-35_1736090133496.jpg)
I'm no longer prediabetic, I've lost one and a half stone and feel more energised, confident and happier. So far, so good. But, how do I maintain the new me? My friends are eager to hear my Ozempic exit plan. Until recently my strategy was to wean myself off gradually.
But six months ago, I swapped Ozempic for Mounjaro, known as the King Kong of weight-loss drugs for its dual action on GLP-1 and GIP receptors, offering extra metabolic benefits. Then a friend suggested the cleverest thing to do was not to come off Mounjaro but to microdose it, as there is growing evidence from America – where these medications are being used off-licence beyond their approved indications for diabetes and obesity – for a raft of other health benefits.
